Skip to content

BRIACELL THERAPEUTICS CORP.

BCTX BCTXL BCTXZ

CIK 0001610820

← back to feed
Revenue (TTM)
—
Q3 Jun 2026
Net Income (TTM)
−$28.71M
−449.1% YoY Q3 Jun 2026
EPS Diluted (TTM)
−$24.34
−42.4% YoY Q3 Jun 2026
Gross Margin
—
Q3 Jun 2026
Operating Margin
—
Q3 Jun 2026
Net Margin
—
Q3 Jun 2026
Free Cash Flow (TTM)
−$26.26M
Q3 Jun 2026
Cash
$6.88M
Q3 Jun 2026
Total Debt
—
Q3 Jun 2026
Shares Outstanding
8.7M sh
Q3 Jun 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings